Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

INO

Inovio Pharmaceuticals Inc

Apr 29 • 03:59PM ET

1.12

-0.02 -2.17 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: MRNA NVAX PFE BNTX GSK JNJ AZN-D VXRT ARCT ADMA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.93	Insider Own	0.50%	Shs Outstand	81.94M	Perf Week	-1.32%
Market Cap	92.18M	Forward P/E	-	EPS next Y	-0.48	Insider Trans	0.00%	Shs Float	81.53M	Perf Month	-32.63%
Enterprise Value	43.04M	PEG	-	EPS next Q	-0.35	Inst Own	45.14%	Short Float	15.66%	Perf Quarter	-26.47%
Income	-84.95M	P/S	1316.88	EPS this Y	36.69%	Inst Trans	17.89%	Short Ratio	7.79	Perf Half Y	-54.82%
Sales	0.07M	P/B	3.22	EPS next Y	58.12%	ROA	-89.14%	Short Interest	12.77M	Perf YTD	-35.34%
Book/sh	0.35	P/C	1.58	EPS next 5Y	-	ROE	-183.47%	52W High	2.98 -62.23%	Perf Year	-41.10%
Cash/sh	0.71	P/FCF	-	EPS past 3/5Y	49.51% 32.44%	ROIC	-277.23%	52W Low	1.03 9.22%	Perf 3Y	-87.86%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-81.47% -61.18%	Gross Margin	-4474.06%	Volatility	3.97% 6.44%	Perf 5Y	-98.64%
Dividend TTM	-	EV/Sales	614.88	EPS Y/Y TTM	51.48%	Oper. Margin	-132871.32%	ATR (14)	0.08	Perf 10Y	-99.11%
Dividend Ex-Date	-	Quick Ratio	1.40	Sales Y/Y TTM	-69.99%	Profit Margin	-130000.00%	RSI (14)	36.27	Recom	1.80
Dividend Gr. 3/5Y	- -	Current Ratio	1.40	EPS Q/Q	109.14%	SMA20	-2.91%	Beta	1.50	Target Price	5.96
Payout	-	Debt/Eq	0.39	Sales Q/Q	-100.00%	SMA50	-23.98%	Rel Volume	0.61	Prev Close	1.15
Employees	112	LT Debt/Eq	0.27	Earnings	Mar 12 AMC	SMA200	-39.74%	Avg Volume	1.64M	Price	1.12
IPO	Dec 08, 1998	Option/Short	Yes / Yes	EPS/Sales Surpr.	116.76% -	Trades		Volume	997,605	Change	-2.17%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)